(GreenMedInfo.com) Every two years, for the past twenty years, a group of approximately 70 scientists have met at different locations around the world to discuss the effects that aluminum has had on living things.
One of the scientists who spoke at the conference this year was keynote speaker Dr. Romain Gherardi, from the Neuromuscular Pathology Expert Centre at Paris-Est Créteil University (UPEC).
According to Ms. Celeste McGovern, who reported on the conference and the presentations, Dr. Gherardi had given an extremely frightening overview of the most novel and profound aluminum research related to vaccination.
“Aluminum oxyhydroxide (Alhydrogel) and aluminium hydroxyphosphate (Adjuphos), are nanomaterials widely used as immune stimulants or “adjuvants” of vaccines. Children have received them in increasing doses from the hepatitis B shot on their day of birth, in diphtheria-tetanus shots given repeatedly in their first six months of life and in pneumococcal, meningitis, HPV vaccines and more.
In at least seven different countries, patients with myalgic chronic fatigue syndrome have been described after they received one of these aluminum-containing vaccines. In France in the late ’90s, Gherardi began taking biopsies of the deltoid muscle of these patients and he discovered lesions in these – clumps of aggregated aluminium hydroxide engulfed in white blood cells called macrophages — at the injection site. Subsequent studies in mice found that aluminum in these cells slowly migrates to their brains where it seems to prefer to settle, permanently. He called the phenomenon Macrophagic Myofasciitis (MMF).”